CD8A and neoplasm: A higher level of CD8+ T cells and interferon gamma were also found among the mice group with better survival receiving neoadjuvant blockade [16].They also observed presence of tumor-directed CD8+ T cells up to 170 days out of tumor inoculation in the neoadjuvant group.